SAN DIEGO--(BUSINESS WIRE)--Lassen Therapeutics, a clinical stage biotech company developing first-in-class antibody therapeutics targeting interleukin-11 receptor (IL-11R) and interleukin-18 binding ...
Crinetics Pharmaceuticals, Inc. announced that eight abstracts detailing their clinical development programs will be presented at the Endocrine Society's Annual Meeting, ENDO 2025. The presentations ...
CAMBRIDGE, Mass., Sept. 17, 2025 (GLOBE NEWSWIRE) -- Ernexa Therapeutics (Nasdaq: ERNA), developing innovative cell therapies for the treatment of advanced cancer and autoimmune disease, today ...
SAN FRANCISCO and BOSTON, Sept. 11, 2025 (GLOBE NEWSWIRE) -- Apogee Therapeutics, Inc., (Nasdaq: APGE), a clinical-stage biotechnology company advancing optimized, novel biologics with potential for ...
Expertise from Forbes Councils members, operated under license. Opinions expressed are those of the author. Picture this: The year is 2030, and you’re living in a world where retailers can predict ...
Jade Biosciences, Inc. announced that new preclinical data on its investigational anti-APRIL monoclonal antibody, JADE101, will be presented at the 62nd European Renal Association Congress in Vienna ...
Company’s NSCLC drug program is focused on overcoming both mutational and non-mutational resistance to 3 rd-generation EGFR inhibitors and outperforms other investigational 4 th-generation inhibitors ...
A longtime anti-vaccine activist gave a presentation at the Centers for Disease Control and Prevention’s vaccine advisory committee meeting Thursday about an issue that has long been considered ...
Tesla’s head of AI, Andrej Karpathy, released a bunch of new data about Autopilot and its features in a new presentation. Unlike most automakers and tech companies working on autonomous driving, Tesla ...
当前正在显示可能无法访问的结果。
隐藏无法访问的结果